Molecular development of the kidney: A review of the results of gene disruption studies

American Journal of Kidney Diseases

Volumn 31, Issue 3, 1998, Pages 383-397

  Lipschutz, Joshua H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; Gene disruption; Kidney; Molecular

Indexed keywords

GENE DISRUPTION; GENE EXPRESSION; KIDNEY DEVELOPMENT; KNOCKOUT MOUSE; MAMMAL; MOLECULAR GENETICS; NONHUMAN; REVIEW;

EID: 0031941550     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9506676     Document Type: Article

References (124)

1. Saxen L: Organogenesis of the Kidney. Cambridge, UK, Cambridge University Press, 1987
2. Moore KL, Persaud TVN: The Developing Human. Philadelphia, PA, Saunders, 1993
3. Wolff E: Specific interactions between tissues during organogenesis. Curr Top Dev Biol 3:65-94, 1968
4. Grobstein C: Inductive interactions in the development of the mouse metanephros. J Exp Zool 130:319-340, 1955
5. Saxen L, Lehtonen E: Embryonic kidney in organ culture. Differentiation 36:2-11, 1987
6. Grobstein C: Trans-filter induction of tubules in mouse metanephrogenic mesenchyme. Exp Cell Res 10:424-440, 1956
7. Saxen L, Koskimies O, Lahti R, Mietinen M, Rapola J, Washiovaa J: Differentiation of kidney mesenchyme in an experimental model system. Adv Morph 7:251-293, 1968
8. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, van Heyningen V, Hastie N: The candidate Wilms' tumor gene is involved in genitourinary development. Nature 346:194-197, 1990
9. Lipschutz JH, Young P, Taguchi O, Cunha GR: Transformation into functional glandular tissue in situ by instructive mesenchymal induction. Kidney Int 49:59-66, 1996
10. Bard JBL, McConnell JE, Davies JA: Towards a genetic basis for kidney development. Mech Dev 48:3-11, 1994
11. Majzoub JA, Muglia LJ: Knockout mice. N Engl J Med 334:904-907, 1996
12. Sanyanusin P, Schimenti LA, McNoe LA, Ward TA, Pierpont MEM, Sullivan MJ, Dobyns WB, Eccles MR: Mutation of the Pax-2 gene in a family with optic colobomas, renal anomalies, and vesiculoureteral reflux. Nat Genet 9: 358-363, 1995
13. Bruening W, Bardessy N, Silverman BL, Cohn RA, Machin GA, Aronson AJ, Housman D, Pelletier J: Germline intronic and exonic mutations in the Wilms' tumor gene (WT1) affecting urogenital development. Nat Genet 1: 144-148, 1992
14. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 74: 679-691, 1993
15. Torres M, Gomez-Pardo E, Dressler GR, Gruss P: Pax-2 controls multiple steps of urogenital development. Development 121:4057-4065, 1995
16. Stark K, Vainio S, Vassileva G, McMahon AP: Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372: 679-683, 1994
17. Lin LH, Doherty DH, Lue JD, Bektesh S, Collins F: GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132, 1993
18. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M: Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382:70-73, 1996
19. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver-Moore K, Rosenthal A: Renal and neuronal abnormalities in mice lacking GDNF. Nature 382:76-79, 1996
20. Pichel JG, Shen L, Sheng HZ, Granholm A, Drago J, Grinberg A, Lee EJ, Huang SP, Saarman M, Hoffer BJ, Sariola H, Westphal H: Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382:73-76, 1996
21. Schuhardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V: Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367:380-383, 1994
22. Harber DA, Housman DE: The genetics of Wilms' tumor. Adv Cancer Res 59:41-68, 1992
23. Wang ZY, Masdden SL, Deuel TF, Rauscher FI: The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 267:21999-22002, 1992
24. Drummond IA, Madden SL, Rohwer NP, Bell GI, Suklhatme VP, Rauscher FI: Repression of the insulin-like growth factor II genes by the Wilms' tumor suppressor gene WT1. Science 257: 674-678, 1992
25. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE: An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms'tumor. Cell 61:1257-1269, 1990
26. Cowell JK, Wadey RB, Haber DA, Call KM, Housman DE, Pritchard J: Structural rearrangements of the WT1 gene in Wilms' tumor cells. Oncogene 6: 595-599, 1991
27. Pelletier M, Breuning W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D: Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447, 1991
28. Baird PN, Groves N, Haber DA, Housman DE, Cowell JK: Identification of mutations in the WT1 gene in tumors from patients with the WAGR syndrome. Oncogene 7:2141-2149, 1992
29. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JBL: The expression of the Wilms' tumor gene, WT-7, in the developing mammalian embryo. Mech Dev 40: 85-97, 1992
30. Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D: Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev 5:1345-1356, 1991
31. Sainio K, Hellstedt P, Kreidberg JA, Saxen L, Sariola H: Differential regulation of two sets of mesonephric tubules by WT1. Development 124:1293-1299, 1997
32. Kleinbrecht J, Selow J, Winkler W: The mouse mutant limb-deformity (Id). Anat Anz 152:313-324, 1982
33. Kreidberg JA: Gene targeting in kidney development. Med Pediatr Oncol 27:445-452, 1996
34. Gruss P, Walther C: Pax in development. Cell 69:719-722, 1992
35. Strachen T, Read AP: Pax genes. Curr Opin Dev Biol 4:427-438, 1994
36. Dressler GR, Douglass EC: Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms' tumor. Proc Natl Acad Sci U S A 89:1179-1183, 1992
37. Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P: Pax-2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 109: 787-795, 1990
38. Pachnis V, Mankoo BS, Costantini F: Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005-1017, 1993
39. Schlessinger J, Ullrich A: Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391, 1992
40. Treanor JJS, Goodman L, Sauvage FD, Stone DM, Poulson KT, Beck CD, Gray C, Armanini MP, Pollack RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A: Characterization of a multicomponent receptor for GDNF. Nature 382:80-83, 1996
41. Hatini V, Tao W, Lai E: Expression of winged helix genes, BF1 and BF2, define adjacent domains within the developing forebrain and retina. J Neurobiol 25:1293-1309, 1994
42. Hromas R, Costa R: The hepatocyte nuclear factor-3/ forkhead transcription regulatory family in development, inflammation, and neoplasia. Crit Rev Oncol Hematol 20: 129-140, 1995
43. Weinstein DC, Altaba AR, Chen WS, Hoodless P, Prezioso VR, Jessell TM, Darnell JE: The winged helix transcription factor HNF-3β is required for notochord development in the mouse embryo. Cell 78: 575-588, 1994
44. Ang SL, Rossant J: HNF-3 beta is essential for node and notochord formation in mouse development. Cell 78: 561-574, 1994
45. Clevidence DE, Overdier DG, Tao W, Qian X, Pani L, Lai E, Costa RH: Identification of nine tissue specific transcription factors of the hepatocyte nuclear fac/ forkhead DNA-binding domain family. Proc Natl Acad Sci U S A 90:3948-3952, 1993
46. Lipschutz JH, Cunha GR, Kopachik W: Identification of DNA transcription factors of the hepatocyte nuclear factor family expressed during kidney development. J Am Soc Nephrol 7:1601, 1996 (abstr)
47. Hatini V, Huh SO, Herzlinger D, Soares VC, Lai E: Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of winged helix transcription factor BF2. Genes Dev 10:1467-1478, 1996
48. Ekblom P, Weller A: Ontogeny of tubulo-interstitial cells. Kidney Int 39:394-400, 1991
49. Gossens CL, Unsworth BR: Evidence for a two-step mechanism operating during in vitro mouse kidney tubulogenesis. J Embryol Exp Morphol 28:615-631, 1972
50. Aufderheide E, Chiquet ER, Ekblom P: Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J Cell Biol 105:599-608, 1987
51. Kingsley DM: The TGF-β superfamily; new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146, 1994
52. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534, 1988
53. Lyons KM, Hogan BLM, Robertson EF: Colocalization of BMP-7 and BMP-2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech Dev 50:71-83, 1995
54. Dudley AT, Lyons KM, Robertson EJ: A requirement for bone morphogenetic prot during development of the mammalian kidney and eye. Genes Dev 9:2795-2807, 1995
55. Ozkaynak E, Reuger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H: OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J 9:2085-2093, 1990
56. Luo G, Hofmann C, Bronckers ALJJ, Sohocki A, Bradley A, Karsenty G: BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820, 1995
57. Busch C, Wasteson A, Westermark B: Release of a cell growth promoting factor from human platelets. Thromb Res 8:493-500, 1976
58. Heldin CH, Westermark B : Platelet derived growth factor: Mechanism of action and possible in vivo function. Cell Regul 1:555-556, 1990
59. Yarden Y, Escobedo JA, Kuang WJ, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U, Fried VA, Ullrich A, Williams LT: Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323:226-232, 1986
60. Hart CE, Forstrom JW, Kelly JD, Seifert RA, Smith RA, Ross R, Murray MJ, Bowen-Pope DF: Two classes of PDGF receptors recognize different isoforms of PDGF. Science 240:1529-1531, 1988
61. Alpers CE, Siefert RA, Hudkins KL, Johnson RJ, Bowen-Pope DR: Developmental patterns of PDGF B-chain, PDGF receptor and aα-actinin expression in human glomerulogenesis. Kidney Int 42:390-399, 1992
62. Abboud HE, Poptic E, DiCorleto P: Production of platelet-derived growth factor-like protein by rat mesangial cells in culture. J Clin Invest 80:675-683, 1987
63. Silver BJ, Jaffer FE, Abboud HE: Platelet-derived growth factor synthesis in mesangial cells: Induction by multiple peptide mitogens. Proc Natl Acad Sci U S A 86:1056-1060, 1989
64. Soriano P: Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev 8:1888-1896, 1994
65. Leveen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8:1875-1887, 1994
66. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992
67. Schnapp LM, Hatch N, Ramos DM, Klimanskaya IV, Sheppard D, Pytela R: The human integrin alpha 8 beta 1 functions as a receptor for tenscin, fibronectin, and vitronectin. J Biol Chem 70:23196-23202, 1995
68. Muller U, Bossy B, Venstrom K, Reichardt LF: Integrin alpha 8 beta I promotes attachment, cell spreading, and neurite outgrowth on fibronectin. Mol Biol Cell 6:433-448, 1995
69. Elices MJ, Urry LA, Hemler ME: Receptor functions for the integrin VLA-3: Fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations. J Cell Biol 112: 169-181, 1991
70. Dedhar S, Jewell K, Rojiani M, Gray V: The receptor for the basement membrane glycoprotein entactin is the integrin alpha3/beta 1. J Biol Chem 267:18908-18914, 1992
71. Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA, Reichardt LF: Integrin αSβ1 is critically important for epithelial mesenchymal interactions during kidney morphogenesis. Cell 88: 603-613, 1997
72. Rahilly MA, Fleming S: Differential expression of integrin alpha chains by renal epithelial cells. J Pathol 167:327-334, 1992
73. Patey N, Halbwachs ML, Droz D, Lesavre P, Noel LH: Distribution of integrin subunits in normal human kidney. Cell Adhes Commun 2:159-167, 1994
74. Ekblom P, Klein G, Ekblom M, Sorokin L: Laminin isoforms and their receptors in the developing kidney. Am J Kidney Dis 17:603-605, 1991
75. Adler S: Characterization of glomerular epithelial cell matrix receptors. Am J Pathol 141:571-578, 1992
76. Korhonen M, Ylanne J, Laitinen L, Cooper HM, Quaranta V, Virtanen I: Distribution of the alpha 1-alpha 6 integrin subunits in human developing and term placenta. Lab Invest 65: 347-356, 1991
77. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R: Alpha 3 b integrin has a crucial role in kidney and lung organogenesis. Development 122:3537-3547, 1996
78. Shawlot W, Behringer RR: Requirement for Lim1 in head-organizer function. Nature 374:425-430, 1995
79. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF: Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 6:2235-2247, 1992
80. Sawai S, Shimono A, Wakamatsu Y, Palmes C, Hanaoka K, Kondoh H: Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 117:1445-1455, 1993
81. Charron J, Malynn BA, Fisher P, Stewart V, Jeannotte L, Goff SP, Robertson EJ, Alt FW: Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev 6:2248-2257, 1992
82. Miner JH, Sanes JR: Molecular and functional defects in kidneys of mice lacking collagen α3(IV): Implications for Alport syndrome. I Cell Biol 135:1403-1413, 1996
83. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC: Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev 10:2981-2992, 1996
84. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC,.Gregory MC, Skolnick MH, Atkin CL, Tryggvason K: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227, 1990
85. Engle SJ, Stockelman MG, Chen J, Boivin G, Yum M, Davies PM, Ying MY, Sahota A, Simmonds HA, Sook PJ, Tischfield JA: Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc Natl Acad Sci U S A 93:5307-5312, 1996
86. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240, 1993
87. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR, Merlie JP: The renal glomerulus of mice lacking s-laminin/laminin β2: Nephrosis despite molecular compensation by laminin β1. Nature Genet 10:400-406, 1995
88. Noakes PG, Gautam M, Mudd J, Sanes JR, Merlie JP: Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin β 2. Nature 374: 258-262, 1995
89. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnuson T: Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 269:230-234, 1995
90. Lo SH, Yu Q, Degenstein L, Chen LB, Fuchs E: Progressive kidney degeneration in mice lacking tensin. J Cell Biol 136:1349-1361, 1997
91. Dinchuck JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, Gorry SA, Trzaskos JM: Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378:406-409, 1995
92. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, Smithies O: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473-482, 1995
93. Maas R, Elfering S, Glaser T, Jepeal L: Deficient outgrowth of the ureteric bud underlies the renal agenesis phenotype in mice manifesting the limb deformity (Id) mutation. Dev Dyn 199:214-228, 1994
94. Gluecksohn-Schoenheimer S: The Sd-strain in mice. Genetics 30:29-38, 1945
95. Gluecksohn-Schoenheimer S: The morphologic mutations of a dominant mutation in mice affecting tail and urogenital system. Genetics 28:340-348, 1943
96. Brandon EP, Idzerda RL, McKnight GS: Targeting the mouse genome: A compendium of knockouts (part 3). Curr Biol 5: 873-881, 1995
97. Brandon EP, Idzerda RL, McKnight GS: Targeting the mouse genome: A compendium of knockouts (part 2). Curr Biol 5: 758-765, 1995
98. Brandon EP, Idzerda RL, McKnight GS: Targeting the mouse genome: A compendium of knockouts (part 1). Curr Biol 5: 625-634, 1995
99. Kedinger M, Simon-Assmann PM, Lacroix B, Marxer A, Hauri HP, Haffen K: Fetal gut mesenchyme induces differentiation of cultured intestinal endodermal and crypt cells. Dev Biol 113:474-483, 1986
100. Hall BK: Epithelial-mesenchymal interactions in cartilage and bone development, in Sawyer RH, Fallon JF (eds): Epithelial-Mesenchymal Interactions in Development. New York, NY, Praeger, 1983, pp 189-214
101. Cunha GR: Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 74:1030-1044, 1994 (suppl)
102. Cunha GR: Growth factors as mediators of androgen action during male urogenital development. Prostate 2:22-25, 1996 (suppl)
103. Lipschutz JH, Samid D, Cunha GR: Phenylacetate is an inhibitor of prostatic growth and development in organ culture. J Urol 155:1762-1770, 1996
104. Lipschutz JH, Foster BA, Cunha GR: Differentiation of rat neonatal ventral prostates grown in organ culture. Prostate 32:35-42, 1997
105. Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cunha GR, Finch PW: Keratinocyte growth factor as a cytokine that mediates mesenchymal-epithelial interaction. EXS 74:191-214, 1995
106. Sugimura Y, Foster BA, Hom YK, Lipschutz JH, Rubin JS, Finch PW, Aaronson SA, Hayashi N, Kawamura J, Cunha GR: Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 40:941-951, 1996
107. Kratochwil K: Tissue combination and organ culture studies in the development of the embryonic mammary gland, in Gwatkin RBL (ed): Developmental Biology: A Comprehensive Synthesis. New York, NY, Plenum, 1987, pp 315-334
108. Korach K: Insights from the study of animals lacking functional estrogen receptor. Science 266:1524-1527, 1994
109. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O: Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 90:11162-11166, 1993
110. Cooke PS, Buchanan DL, Young P, Setiawan T, Brody J, Korach KS, Taylor J, Lubahn DB, Cunha GR: Stromal estrogen receptors (ER) mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A 94:6535-6540, 1997
111. Li HMH, Witte DP, Weinstein M, Branford W, Li H, Small K, Potter S: Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility. Development 121:1373-1385, 1995
112. Davis AP, Witte DP, Hsieh-Li HM, Potter SS, Capecchi MR: Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11. Nature 375:791-795, 1995
113. Davis AP, Capecchi MR: Axial homeosis and appendicular skeleton defects in mice with a targeted disruption of hoxd-11. Development 120:2187-2198, 1994
114. Small KM, Potter SS: Homeotic transformations and limb defects in Hox All mutant mice. Genes Dev 7:2318-2328, 1993
115. Sonnenberg E, Weidner KM, Birchmeier C: Expression of the met-receptor and its ligand, HGF-SF, during mouse embryo genesis. EXS 65:381-394, 1993
116. Montesano R, Schaller G, Orci L: Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 66:697-711, 1991
117. Woolf AS, Kolatsi-Joannou M, Hardman P, Andermarcher E, Moorby C, Fine LG, Jat PS, Noble MD, Gherardi E: Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol 128:171-184, 1995
118. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C: Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373:699-702, 1995
119. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, Kitamura N: Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373:702-705, 1995
120. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C: Essential role for the c-met receptor in the migration of myogenic precurser cells into the limb bud. Nature 376:768-771, 1995
121. Chambers CA: TKO'ed: Lox, stock and barrel. Bioessays 16:865-867, 1994
122. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K: Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265:103-106, 1994
123. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline responsive promoters. Proc Natl Acad Sci U S A 89:5547-5551, 1992
124. Schockett PE, Schatz DG: Diverse strategies for tetracycline regulated inducible gene expression. Proc Natl Acad Sci U S A 93:5173-5176, 1996